transcera
Boston, United States · Founded 2021 · $5.4M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- transcera.com
- Total Funding
- $5.4M
- Last Round
- $4.4M SeedJul 2021
- Rounds
- 2
About
Venture-backed biotech translating Harvard lab discoveries into improved biologic drug delivery for chronic diseases.
Summary
transcera is a Biotech company based in Boston, United States, founded in 2021. It has raised $5.4M in total across 2 rounds, most recently a $4.4M Seed round in Jul 2021. Investors include Xora Innovation, Pear VC and Digitalis Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.